Professor of Rhinology & Olfactology
Norwich, UNITED KINGDOM
He is the chief investigator of a large trial to compare sinus surgery and medical treatment for patients with chronic sinusitis.
MB ChB, Medicine
Daily Express online
One way coronavirus could be distinguished is through loss of taste and smell, according to Arnold Monto, an epidemiologist at the University of Michigan School of Public Health, and Carl Philpott, a University of East Anglia ear, nose and throat expert.view more
The Independent online
Professor Carl Philpott, director of medical affairs and research at charity Fifth Sense, explained to The Independent that as common colds and viruses often cause initial congestion of the nose, this can lead to “post-viral smell loss”.view more
It can also be dangerous, as Professor Carl Philpott, from UEA’s Norwich Medical School, explains: “One really big problem was around hazard perception – not being able to smell food that had gone off, or not being able to smell gas or smoke. This had resulted in serious near misses for some.”view more
The UK has joined the US, Europe and the World Health Organisation by including loss of smell or taste as an officially recognised symptom of Covid-19 – thanks in part to an international research project involving Professor Carl Philpott at the University of East Anglia.view more
The Guardian online
As the coronavirus pandemic swept around the globe, anecdotal reports began to emerge about a strange symptom: people were losing their sense of taste and smell. To find out whether this effect is really down to Sars-CoV-2, and if so, why, Ian Sample talks to Carl Philpott.view more
Loss of smell is a recognised symptom of COVID-19 in the UK. However, it was only added to the official list of symptoms on May 18, a full month after the World Health Organization recognised it as a symptom. Before this time, any member of NHS staff reporting a loss of smell – especially in the absence of other symptoms – would not have been advised to self-isolate.
A gentleman with recurrent epiphora after two failed endonasal dacryocystorhinostomies was found to have a squamous cell carcinoma of the lacrimal sac at his third operation via an external approach. CT showed contralateral nodal involvement; however, biopsy of the node found it to be histologically distinct from the lacrimal sac lesion. A PET-CT revealed a second primary lesion located at the contralateral palatine tonsil.
To systematically review the currently available evidence investigating the association between olfactory dysfunction (OD) and the novel coronavirus (COVID‐19). To analyse the prevalence of OD in patients who have tested positive on polymerase chain reaction (PCR) for COVID‐19.
On May 18 2020, Public Health England added new loss of taste or smell to the recognised symptoms associated with COVID-19, consistent with those listed by the Centers of Disease Control and Prevention (Atlanta, GA, USA) and WHO.
COVID-19 has heterogeneous manifestations, though one of the most common symptoms is a sudden loss of smell (anosmia or hyposmia). We investigated whether olfactory loss is a reliable predictor of COVID-19. Methods: This preregistered, cross-sectional study used a crowdsourced questionnaire in 23 languages to assess symptoms in individuals self-reporting recent respiratory illness.